back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-08-21 14:52 Tx date 2019-08-19 |
$NHP
Mondias Natural Products Inc. |
Frankham, Patrick Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+700,000 vol |
700,000 | |
| Filed 2019-08-21 14:42 Tx date 2019-08-19 |
$NHP
Mondias Natural Products Inc. |
Frankham, Patrick Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-06-05 13:04 Tx date 2019-06-03 |
$PVOT
Pivot Pharmaceuticals Inc. |
Frankham, Patrick Charles
4 - Director of Issuer
Holder: Kathleen Caruso (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,760
+8,000 vol $0.47 each |
108,400 | |
| Filed 2018-04-17 Tx date 2018-04-10 |
$PVOT
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Frankham, Patrick Charles
4 - Director of Issuer
Holder: Kathleen Caruso (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$348.00
+400 vol $0.87 each |
100,400 | |
| Filed 2018-03-05 Tx date 2018-01-23 |
$PVOT
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Frankham, Patrick Charles
4 - Director of Issuer
Holder: Inflexion Point Healthcare (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-100,000 vol |
0 | |
| Filed 2018-03-05 Tx date 2014-07-24 |
$PVOT
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Frankham, Patrick Charles
4 - Director of Issuer
Holder: Kathleen Caruso (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-05 Tx date 2018-01-23 |
$PVOT
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Frankham, Patrick Charles
4 - Director of Issuer
Holder: Kathleen Caruso (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+100,000 vol |
100,000 | |
| Filed 2017-12-14 Tx date 2015-07-31 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Frankham, Patrick Charles
4 - Director of Issuer
Holder: Inflexion Point Healthcare (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$10,000
+100,000 vol $0.10 each |
100,000 | |
| Filed 2017-12-14 Tx date 2014-07-24 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Frankham, Patrick Charles
4 - Director of Issuer
Holder: Inflexion Point Healthcare (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-12-14 Tx date 2015-12-15 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Frankham, Patrick Charles
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$200,000
+2,000,000 vol $0.10 each |
2,000,000 | |
| Filed 2017-12-14 Tx date 2016-12-15 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Frankham, Patrick Charles
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$200,000
+2,000,000 vol $0.10 each |
4,000,000 |